The U.S. Food and Drug Administration has approved the Abbreviated New Drug Application (ANDA) number 087315 submitted by Alpharma US Pharms. The application covers a topical lotion formulation containing 1% hydrocortisone.
The product, identified as Hydrocortisone lotion (product number 001), is classified with a discontinued marketing status. The original submission (submission number 1) received an approval status on June 7, 1982.
Regulatory UpdatesSep 23, 2026•1 min read
FDA Approves ANDA087315 for Hydrocortisone 1% Topical Lotion
The FDA has approved ANDA087315 submitted by Alpharma US Pharms for a 1% hydrocortisone topical lotion, currently listed as discontinued.
Compiled by the PharmaCountry team · Source: FDA.gov
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating